U.S. Markets closed

Albemarle reports strong 2016 earnings finish and record cash flow from operations

CHARLOTTE, N.C., Feb. 27, 2017 /PRNewswire/ --

Fourth quarter 2016 highlights:

  • Fourth quarter earnings were $602.1 million, or $5.30 per diluted share, including $546.3 million in after-tax gains related to the sale of the Chemetall Surface Treatment business
  • Fourth quarter adjusted EBITDA was $187.4 million, an increase of 12% over the prior year, excluding the impact of divestitures
  • Full year cash from operations was a record $733.4 million, an increase of 103% over the prior year
  • Completed sale of Chemetall Surface Treatment business on December 14 and completed the acquisition of the lithium hydroxide and lithium carbonate conversion assets of Jiangxi Jiangli New Materials Science and Technology Co. Ltd. on December 31
  • Net debt to adjusted EBITDA ratio at December 31, 2016 was 0.1x, a significant step in our deleveraging efforts

Three Months Ended


Year Ended


December 31,


December 31,

In thousands, except per share amounts

2016


2015


2016


2015

Net sales

$

696,655


$

722,610


$

2,677,203


$

2,826,429

Net income from continuing operations

$

50,304


$

169,275


$

478,638


$

327,588

Net income attributable to Albemarle Corporation

$

602,090


$

174,252


$

643,675


$

334,906

Adjusted EBITDA

$

187,384


$

174,481


$

758,217


$

756,000

Diluted earnings per share from continuing operations

$

0.37


$

1.43


$

3.90


$

2.71

Diluted earnings per share attributable to Albemarle
Corporation

$

5.30


$

1.55


$

5.68


$

3.00

   Non-operating pension and OPEB items(a)

0.16


(0.20)


0.16


(0.22)

   Non-recurring and other unusual items(b)

0.25


(0.27)


(0.49)


1.03

   Discontinued operations(c)

(4.93)


(0.12)


(1.78)


(0.29)

Adjusted diluted earnings per share from continuing
operations(d)

$

0.78


$

0.96


$

3.57


$

3.52













See accompanying notes (a) through (d) to the condensed consolidated financial information and non-GAAP reconciliations.

 

Albemarle Corporation (ALB) reported fourth quarter 2016 net sales of $696.7 million, net income from continuing operations of $50.3 million and adjusted EBITDA of $187.4 million.

"Our three reportable segments again delivered strong results in the fourth quarter capping a year in which our three GBU's delivered adjusted EBITDA growth of $96 million, an increase of 13% compared to 2015. Full year adjusted EBITDA growth of 34% in Lithium and 21% in Refining Solutions was especially impressive," said Luke Kissam, Albemarle's Chairman, CEO and President. "We also completed key strategic initiatives in the quarter that accelerate our transformation into a premier, high growth specialty chemicals company. The sale of the Chemetall Surface Treatment business to BASF SE was completed, fully restoring our balance sheet, and substantially increasing our financial flexibility. We finalized the agreement with CORFO that more than triples our Lithium quota in Chile, and secures our access to the best lithium reserve in the world through 2043. Finally, we closed on the acquisition of the lithium assets of Jiangxi Jiangli New Materials Science and Technology Co. Ltd., which makes us an owner of high quality spodumene conversion assets and makes us an integrated producer of lithium salts from spodumene given our ownership position in the Talison mines in Australia."

Outlook

Our 2016 performance and strategic actions have positioned Albemarle for another strong year of growth in 2017. We expect net sales to range between $2.8 billion and $2.95 billion, with adjusted EBITDA between $800 million and $840 million, and adjusted diluted earnings per share between $4.00 and $4.25.

Results

Net income from continuing operations for the fourth quarter 2016 was $50.3 million, or $0.37 per diluted share (after income attributable to noncontrolling interests), compared to $169.3 million, or $1.43 per diluted share in the fourth quarter 2015. The decrease in 2016 was primarily related to an increase in discrete tax charges of $0.55 per diluted share, an increase in mark-to-market actuarial losses of $0.35 per diluted share and the impact of a higher tax rate in 2016 due to the level and geographic mix of income.  Additionally, adjusted EBITDA increased by $12.9 million, which includes a decrease of $24.5 million in All Other as compared to prior year related to divestitures and the FCS business. See notes to the condensed consolidated financial information for further details. Fourth quarter 2016 adjusted net income from continuing operations was $88.8 million, or $0.78 per diluted share, compared to $108.1 million, or $0.96 per diluted share, for fourth quarter 2015 (see notes to the condensed consolidated financial information). The Company reported net sales of $696.7 million in fourth quarter 2016, down from net sales of $722.6 million in the fourth quarter of 2015, driven by the divestitures of $70.9 million, partially offset by the favorable impact of higher sales volumes, as well as favorable price and mix impacts in certain businesses and favorable currency exchange impacts.

Net income from continuing operations for the full year 2016 was $478.6 million, or $3.90 per diluted share (after income attributable to noncontrolling interests), compared to $327.6 million, or $2.71 per diluted share, for the full year 2015. The full year 2016 includes the gains related to the sales of the metal sulfides and minerals-based flame retardants and specialty chemicals businesses of $1.02 per diluted share. Increases in adjusted EBITDA for our reportable segments of $96.1 million were partially offset by decreased adjusted EBITDA in All Other due to divestitures, and lower adjusted EBITDA in Corporate of $54.7 million due primarily to 2015 currency gains related to cash denominated in U.S. Dollars held by foreign subsidiaries where the European Union Euro serves as the functional currency, related to the acquisition of Rockwood. Adjusted net income from continuing operations for the full year 2016 was $403.8 million, or $3.57 per diluted share, compared to $392.2 million, or $3.52 per diluted share, for the full year 2015 (see notes to the condensed consolidated financial information). Net sales for the full year 2016 were $2.68 billion, down from net sales of $2.83 billion, driven primarily by the divestitures of $265.3 million, partially offset by the favorable impact of higher sales volumes, as well as favorable price and mix impacts in certain businesses and favorable currency exchange impacts.

On December 14, 2016, the Company closed the sale of the Chemetall Surface Treatment business to BASF SE for cash proceeds of approximately $3.1 billion, net of estimated purchase price adjustments, and recorded an after-tax gain of $135.0 million related to the sale of this business. We used a portion of the proceeds to significantly reduce leverage, including repaying the outstanding balance of the term loan in December 2016. In the second quarter of 2016, the Company determined that the business qualified for discontinued operations treatment, and as such began accounting for its assets and liabilities as held for sale. The financial results of the disposal group and related gain on sale have been presented as discontinued operations in the consolidated statements of income and excluded from segment results for all periods presented.

Quarterly Segment Results

Effective January 1, 2016, our former Performance Chemicals reportable segment was split into two separate reportable segments: (1) Lithium and Advanced Materials, which includes Lithium and Performance Catalyst Solutions and Curatives ("PCS"), and (2) Bromine Specialties. For comparison purposes, prior year periods have been reclassified to conform to the current segments. This split did not affect the Refining Solutions reportable segment, which is presented on the same basis as in the prior year.

Lithium and Advanced Materials reported net sales of $278.3 million in the fourth quarter of 2016, an increase of 30.0% from fourth quarter 2015 net sales of $214.0 million. Net sales were impacted by $0.9 million of favorable currency exchange impacts as compared to the prior year. The remaining $63.4 million increase in net sales was primarily due to favorable pricing impacts and increased sales volumes. Adjusted EBITDA for Lithium and Advanced Materials was $102.5 million, an increase of 31.6% from fourth quarter 2015 results of $77.9 million. Adjusted EBITDA was impacted by $1.2 million of favorable currency exchange impacts as compared to the prior year. The remaining $23.4 million increase in adjusted EBITDA was primarily due to favorable pricing impacts partially offset by higher selling and administrative costs.

Bromine Specialties reported net sales of $194.5 million in the fourth quarter of 2016, an increase of 13.4% from fourth quarter 2015 net sales of $171.5 million. Net sales were impacted by $1.3 million of favorable currency exchange impacts as compared to the prior year. The remaining $21.7 million increase in net sales was primarily due to higher sales volumes. Adjusted EBITDA for Bromine Specialties was $46.9 million, an increase of 11.2% from fourth quarter 2015 results of $42.2 million. Adjusted EBITDA was impacted by $1.1 million of favorable currency exchange impacts as compared to the prior year. The remaining $3.6 million increase in adjusted EBITDA was primarily driven by higher sales volumes.

Refining Solutions reported net sales of $193.1 million in the fourth quarter of 2016, a decrease of 3.7% from net sales of $200.4 million in the fourth quarter of 2015. Net sales were impacted by $0.6 million of unfavorable currency exchange impacts as compared to the prior year. The remaining $6.7 million decrease in net sales was primarily driven by lower sales volumes and unfavorable pricing impacts. Adjusted EBITDA for Refining Solutions was $57.3 million in the fourth quarter of 2016, an increase of 8.8% from fourth quarter 2015 results of $52.7 million. Adjusted EBITDA was impacted by $0.3 million of favorable currency exchange impacts as compared to the prior year. The remaining $4.9 million increase in adjusted EBITDA was primarily due to higher equity income from our joint venture Nippon Ketjen Company Limited due to sales volumes as well as a favorable sales mix.

On January 4, 2016, we closed the sale of the metal sulfides business, and on February 1, 2016, we closed the sale of the minerals-based flame retardants and specialty chemicals business. The divestiture of these businesses reduced net sales and adjusted EBITDA for the fourth quarter of 2016 as compared to the prior year period by $70.9 million and $7.8 million, respectively.

All Other net sales were $30.0 million in the fourth quarter of 2016, a decrease of 77.5% from net sales of $133.4 million in the fourth quarter of 2015. Excluding the impact of the divested businesses, All Other net sales decreased by $32.5 million compared to the prior year due to lower sales volumes and unfavorable pricing impacts for fine chemistry services. All Other adjusted EBITDA was a loss of less than $0.1 million in the fourth quarter of 2016, a decrease of 100.2% from fourth quarter 2015 results of $24.5 million. Excluding the impact of the divested businesses, All Other adjusted EBITDA decreased by $16.7 million compared to the prior year predominantly due to lower overall sales for fine chemistry services.

In summary, total net sales of $696.7 million in the fourth quarter of 2016, a decrease of $26.0 million, or 3.6%, from fourth quarter 2015 net sales of $722.6 million, were negatively impacted by the divestiture of our metal sulfides and minerals-based flame retardants and specialty chemicals businesses, which reduced revenues versus the prior year by $70.9 million, partially offset by favorable currency impacts of $1.6 million. Excluding currency exchange impacts and the impact of the divested businesses, net sales for the period increased 6.0% as compared to the prior year. Total adjusted EBITDA of $187.4 million in the fourth quarter of 2016, an increase of $12.9 million, or 7.4%, from fourth quarter 2015 adjusted EBITDA of $174.5 million, was favorably impacted by $8.1 million currency exchange (including $5.5 million of unfavorable currency exchange impacts on corporate results) as well as the divestiture of our metal sulfides and minerals-based flame retardants and specialty chemicals business, which reduced adjusted EBITDA versus the prior year by $7.8 million. Excluding currency exchange impacts and the impact of the divested businesses, adjusted EBITDA for the fourth quarter 2016 increased 7.0% as compared to the prior year.

Corporate Results

Corporate adjusted EBITDA was a loss of $19.4 million in the fourth quarter of 2016 compared to a loss of $22.8 million in the fourth quarter of 2015. The improvement in Corporate adjusted EBITDA was primarily due to foreign currency gains in the fourth quarter of 2016 of $5.5 million partially offset by increased compensation costs.

Income Taxes

Our effective income tax rates for the fourth quarter of 2016 and 2015 of 49.5% and (23.5)%, respectively, are influenced by non-recurring, other unusual and non-operating pension and OPEB items (see notes to the condensed consolidated financial information). Our adjusted effective income tax rates, which exclude non-recurring, other unusual and non-operating pension and OPEB items, were 28.3% and 11.6% for the fourth quarter of 2016 and 2015, respectively, and continue to be influenced by the level and geographic mix of income. The effective tax rate in 2015 was driven down by a variety of factors including mix of income and planning related to the Rockwood acquisition. Our effective income tax rates for the year ended December 31, 2016 and 2015 were 18.7% and 3.6%, respectively, and excluding non-recurring, other unusual and non-operating pension and OPEB items, 20.8% and 23.1%, respectively.

Cash Flow

Our cash flow from operations was approximately $733.4 million for the year ended December 31, 2016, up 103% versus the same period in 2015. We had $2.27 billion in cash and cash equivalents at December 31, 2016, as compared to $213.7 million at December 31, 2015. Cash on hand, cash provided by operations, net borrowings and net proceeds from divestitures of $3.33 billion funded $1.25 billion of debt repayments, including the full repayment of the outstanding term loan, $196.7 million of capital expenditures for plant, machinery and equipment and dividends to shareholders of $135.4 million during the year ended December 31, 2016. The change in working capital increased $239.2 million for the year ended December 31, 2016 primarily as a result of the increase in income taxes payable from the gain on the sale of the Chemetall Surface Treatment business of $253.0 million.

Earnings Call

The Company's performance for the fourth quarter ended December 31, 2016 will be discussed on a conference call at 9:00 AM Eastern time on February 28, 2017. The call can be accessed by dialing 888-713-4211 (International Dial-In # 617-213-4864), and entering conference ID 65384948. The Company's earnings presentation and supporting material can be accessed through Albemarle's website under Investors at www.albemarle.com.

About Albemarle

Albemarle Corporation (ALB), headquartered in Charlotte, NC, is a global specialty chemicals company with leading positions in lithium, bromine and refining catalysts. We power the potential of companies in many of the world's largest and most critical industries, from energy and communications to transportation and electronics. Working side-by-side with our customers, we develop value-added, customized solutions that make them more competitive. Our solutions combine the finest technology and ingredients with the knowledge and know-how of our highly experienced and talented team of operators, scientists and engineers.

Discovering and implementing new and better performance-based sustainable solutions is what motivates all of us. We think beyond business-as-usual to drive innovations that create lasting value. Albemarle employs approximately 4,500 people and serves customers in approximately 100 countries. We regularly post information to www.albemarle.com, including notification of events, news, financial performance, investor presentations and webcasts, non-GAAP reconciliations, SEC filings and other information regarding our company, its businesses and the markets it serves.

Forward-Looking Statements

Some of the information presented in this press release and the conference call and discussions that follow, including, without limitation, product development, changes in productivity, market trends, price, expected growth and earnings, input costs, surcharges, tax rates, stock repurchases, dividends, cash flow generation, costs and cost synergies, portfolio diversification, economic trends, outlook and all other information relating to matters that are not historical facts may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. There can be no assurance that actual results will not differ materially. Factors that could cause actual results to differ materially include, without limitation: changes in economic and business conditions; changes in financial and operating performance of our major customers and industries and markets served by us; the timing of orders received from customers; the gain or loss of significant customers; competition from other manufacturers; changes in the demand for our products; limitations or prohibitions on the manufacture and sale of our products; availability of raw materials; changes in the cost of raw materials and energy; changes in our markets in general; fluctuations in foreign currencies; changes in laws and government regulation impacting our operations or our products; the occurrence of regulatory proceedings, claims or litigation; the occurrence of cybersecurity breaches, terrorist attacks, industrial accidents, natural disasters or climate change; the inability to maintain current levels of product or premises liability insurance or the denial of such coverage; political unrest affecting the global economy; political instability affecting our manufacturing operations or joint ventures; changes in accounting standards; the inability to achieve results from our global manufacturing cost reduction initiatives as well as our ongoing continuous improvement and rationalization programs; changes in the jurisdictional mix of our earnings and changes in tax laws and rates; changes in monetary policies, inflation or interest rates; volatility and substantial uncertainties in the debt and equity markets; technology or intellectual property infringement; decisions we may make in the future; the ability to successfully execute, operate and integrate acquisitions and divestitures; and the other factors detailed from time to time in the reports we file with the SEC, including those described under "Risk Factors" in our Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q. These forward-looking statements speak only as of the date of this press release. We assume no obligation to provide any revisions to any forward-looking statements should circumstances change, except as otherwise required by securities and other applicable laws.

 

Albemarle Corporation and Subsidiaries

Consolidated Statements of Income

(In Thousands Except Per Share Amounts) (Unaudited)






Three Months Ended


Year Ended


December 31,


December 31,


2016


2015


2016


2015

Net sales

$

696,655


$

722,610


$

2,677,203


$

2,826,429

Cost of goods sold(a)(b)

455,689


484,837


1,706,627


1,966,196

Gross profit

240,966


237,773


970,576


860,233

Selling, general and administrative expenses(a)(b)

125,476


47,768


380,464


300,440

Research and development expenses(b)

19,091


21,863


80,475


89,187

Restructuring and other, net(b)




(6,804)

Gain on sales of businesses, net(b)



(122,298)


Acquisition and integration related costs(b)

13,047


15,128


57,384


132,299

Operating profit

83,352


153,014


574,551


345,111

Interest and financing expenses(b)

(18,321)


(19,457)


(65,181)


(81,650)

Other income (expenses), net(b)

5,154


(2,951)


5,894


47,283

Income from continuing operations before income taxes
and equity in net income of unconsolidated investments

70,185


130,606


515,264


310,744

Income tax expense (benefit)(b)

34,728


(30,646)


96,263


11,134

Income from continuing operations before equity in net
income of unconsolidated investments

35,457


161,252


419,001


299,610

Equity in net income of unconsolidated investments (net of
tax)(b)

14,847


8,023


59,637


27,978

Net income from continuing operations

50,304


169,275


478,638


327,588

Income from discontinued operations (net of tax)(c)

559,974


13,402


202,131


32,476

Net income

610,278


182,677


680,769


360,064

Net income attributable to noncontrolling interests

(8,188)


(8,425)


(37,094)


(25,158)

Net income attributable to Albemarle Corporation

$

602,090


$

174,252


$

643,675


$

334,906

Basic earnings per share







Continuing operations

$

0.37


$

1.43


$

3.93


$

2.72

Discontinued operations

4.98


0.12


1.80


0.29


$

5.35


$

1.55


$

5.73


$

3.01

Diluted earnings per share







Continuing operations

$

0.37


$

1.43


$

3.90


$

2.71

Discontinued operations

4.93


0.12


1.78


0.29


$

5.30


$

1.55


$

5.68


$

3.00

Weighted-average common shares outstanding – basic

112,487


112,207


112,379


111,182

Weighted-average common shares outstanding – diluted

113,563


112,608


113,239


111,556









See accompanying notes to the condensed consolidated financial information.





 

 

Albemarle Corporation and Subsidiaries

Condensed Consolidated Balance Sheets

(In Thousands) (Unaudited)






December 31,


December 31,


2016


2015

ASSETS




Cash and cash equivalents

$

2,269,756


$

213,734

Other current assets

1,036,862


975,336

Assets held for sale


641,932

Total current assets

3,306,618


1,831,002

Property, plant and equipment

3,910,522


3,700,472

Less accumulated depreciation and amortization

1,550,382


1,379,377

Net property, plant and equipment

2,360,140


2,321,095

Noncurrent assets held for sale


2,971,455

Other assets and intangibles

2,494,449


2,474,402

Total assets

$

8,161,207


$

9,597,954

LIABILITIES AND EQUITY




Current portion of long-term debt

$

247,544


$

674,994

Other current liabilities

892,559


612,093

Liabilities held for sale


329,598

Total current liabilities

1,140,103


1,616,685

Long-term debt

2,121,718


3,142,163

Noncurrent liabilities held for sale


464,207

Other noncurrent liabilities

544,043


588,734

Deferred income taxes

412,739


384,852

Albemarle Corporation shareholders' equity

3,795,062


3,254,392

Noncontrolling interests

147,542


146,921

Total liabilities and equity

$

8,161,207


$

9,597,954







See accompanying notes to the condensed consolidated financial information.

 

 

Albemarle Corporation and Subsidiaries

Selected Consolidated Cash Flow Data

(In Thousands) (Unaudited)




Year Ended


December 31,


2016


2015

Cash and cash equivalents at beginning of year

$

213,734


$

2,489,768

Cash and cash equivalents at end of period

$

2,269,756


$

213,734

Sources of cash and cash equivalents:




Net income

$

680,769


$

360,064

Cash proceeds from divestitures, net

3,325,571


8,883

Proceeds from borrowings of long-term debt


2,250,000

Other borrowings, net


54,625

Dividends received from unconsolidated investments and nonmarketable
securities

43,759


59,912

Return of capital from unconsolidated investment


98,000

Decrease in restricted cash


57,550

Working capital changes(e)

239,195


Uses of cash and cash equivalents:




Working capital changes


(41,534)

Capital expenditures

(196,654)


(227,649)

Acquisition of Rockwood, net of cash acquired


(2,051,645)

Other acquisitions, net of cash acquired

(126,747)


(48,845)

Cash payments related to acquisitions and other

(81,987)


Repayments of long-term debt

(1,252,302)


(2,626,241)

Repayments of other borrowings, net

(163,721)


Pension and postretirement contributions

(20,068)


(21,613)

Dividends paid to shareholders

(135,353)


(119,302)

Dividends paid to noncontrolling interests

(35,855)


(23,286)

Non-cash and other items:




Depreciation and amortization

226,169


260,076

Gain associated with restructuring and other


(6,804)

Gain on sales of businesses, net

(510,278)


Pension and postretirement expense (benefit)

41,546


(38,817)

Deferred income taxes

21,121


(136,298)

Equity in net income of unconsolidated investments (net of tax)

(61,534)


(30,999)





See accompanying notes to the condensed consolidated financial information.

 

 

Albemarle Corporation and Subsidiaries

Consolidated Summary of Segment Results

(In Thousands) (Unaudited)






Three Months Ended


Year Ended


December 31,


December 31,


2016


2015


2016


2015

Net sales:








Lithium and Advanced Materials

$

278,266


$

213,993


$

968,216


$

834,590

Bromine Specialties

194,513


171,462


792,425


775,729

Refining Solutions

193,093


200,420


732,137


729,261

All Other

30,001


133,437


180,988


471,434

Corporate

782


3,298


3,437


15,415

Total net sales

$

696,655


$

722,610


$

2,677,203


$

2,826,429









Adjusted EBITDA:








Lithium and Advanced Materials

$

102,499


$

77,879


$

363,360


$

312,867

Bromine Specialties

46,949


42,222


226,926


222,653

Refining Solutions

57,343


52,685


238,963


197,595

All Other

(38)


24,453


14,772


53,993

Corporate(a)

(19,369)


(22,758)


(85,804)


(31,108)

Total adjusted EBITDA

$

187,384


$

174,481


$

758,217


$

756,000













Lithium and Advanced Materials - details by product category:






Three Months Ended


Year Ended


December 31,


December 31,


2016


2015


2016


2015

Net sales:








Lithium

$

208,173


$

139,033


$

668,852


$

508,844

PCS

70,093


74,960


299,364


325,746

Total Lithium and Advanced Materials

$

278,266


$

213,993


$

968,216


$

834,590









Adjusted EBITDA:








Lithium

$

89,097


$

57,131


$

285,714


$

213,464

PCS

13,402


20,748


77,646


99,403

Total Lithium and Advanced Materials

$

102,499


$

77,879


$

363,360


$

312,867













See accompanying notes to the condensed consolidated financial information and non-GAAP reconciliations below.

 

Notes to the Condensed Consolidated Financial Information

(a)   Non-operating pension and OPEB items, consisting of MTM actuarial gains/losses, settlements/curtailments, interest cost and expected return on assets, are not allocated to our reportable segments and are included in the Corporate category. Although non-operating pension and OPEB items are included in Cost of goods sold and Selling, general and administrative expenses in accordance with GAAP, we believe that these components of pension cost are mainly driven by market performance, and we manage these separately from the operational performance of our businesses. Non-operating pension and OPEB items included in Cost of goods sold and Selling, general and administrative expenses were as follows (in millions):


Three Months Ended


Year Ended


December 31,


December 31,


2016


2015


2016


2015

Cost of goods sold:








MTM actuarial loss (gain)

$

0.3


$

(2.0)


$

0.3


$

(2.0)

Interest cost and expected return on assets, net

(0.2)


(0.4)


(0.6)


(1.7)

Total

$

0.1


$

(2.4)


$

(0.3)


$

(3.7)









Selling, general and administrative expenses:








MTM actuarial loss (gain)

$

26.3


$

(28.1)


$

26.3


$

(28.1)

Interest cost and expected return on assets, net

(0.2)


(0.9)


(0.4)


(3.5)

Total

$

26.1


$

(29.0)


$

25.9


$

(31.6)

 

The MTM actuarial loss (gain) was $26.6 million and ($30.1) million for the three months and years ended December 31, 2016 and 2015, respectively, and resulted from the annual remeasurement of our pension and OPEB plans in the fourth quarter.

(b)   In addition to the non-operating pension and OPEB items disclosed above, we have identified certain other items from continuing operations and excluded them from our adjusted net income calculation for the periods presented. A listing of these items, as well as a detailed description of each follows below (per diluted share):


Three Months Ended


Year Ended


December 31,


December 31,


2016


2015


2016


2015

Utilization of inventory markup(1)

$


$

0.02


$


$

0.60

Write-off of research and development fixed assets(2)



0.01


Restructuring and other, net(3)


(0.01)



(0.05)

Gain on sales of businesses, net(4)



(1.02)


Acquisition and integration related costs(5)

0.05


0.06


0.31


0.76

Loss on extinguishment of debt(6)

0.01


0.03


0.01


0.03

Interest and financing expenses related to Rockwood
acquisition(7)




0.01

Other(8)

0.03



0.02


0.03

Impairment of unconsolidated investment(9)


0.02



0.02

Discrete tax items(10)

0.16


(0.39)


0.18


(0.37)

Total non-recurring and other unusual items

$

0.25


$

(0.27)


$

(0.49)


$

1.03

 

(1)   In connection with the acquisition of Rockwood, the Company valued Rockwood's existing inventory at fair value as of the acquisition date, which resulted in a markup of the underlying net book value of the inventory. The inventory markup was expensed over the estimated remaining selling period. For the three months ended December 31, 2015, $0.5 million was included in Cost of goods sold and Equity in net income of unconsolidated investments was reduced by $0.2 million related to the utilization of the inventory markup. For the year ended December 31, 2015, $55.9 million ($40.0 million after income taxes, or $0.36 per share) was included in Cost of goods sold, and Equity in net income of unconsolidated investments was reduced by $27.1 million ($0.24 per share), related to the utilization of the inventory markup.

(2)   Included in Research and development expenses for the year ended December 31, 2016 is a loss of $1.4 million ($1.1 million after income taxes, or $0.01 per share) resulting from the write-off of research and development fixed assets in China.

(3)   Included in Restructuring and other, net, for the year ended December 31, 2015 is a gain of $6.8 million ($5.4 million after income taxes, or $0.05 per share) recognized upon the sale of land in Avonmouth, UK, which was utilized by the phosphorus flame retardants business we exited in 2012.

(4)   Included in Gain on sales of businesses, net, for the year ended December 31, 2016 is $11.5 million ($11.3 million after income taxes, or $0.10 per share) related to the sale of the metal sulfides business and $112.3 million ($105.8 million after income taxes, or $0.93 per share) related to the sale of the minerals-based flame retardants and specialty chemicals business. In addition, Gain on sales of businesses, net, for the year ended December 31, 2016 includes a loss of $1.5 million, or $0.01 per share, on the sale of our wafer reclaim business.

(5)   Acquisition and integration related costs consisted of the following:

Three months ended December 31, 2016 -

  • $9.7 million of integration costs resulting from the acquisition of Rockwood and $3.3 million in connection with other significant projects. After income taxes, these charges totaled $5.9 million, or $0.05 per share.

Year ended December 31, 2016 -

  • $52.1 million of integration costs resulting from the acquisition of Rockwood and $5.3 million in connection with other significant projects. After income taxes, these charges totaled $35.4 million, or $0.31 per share.

Three months ended December 31, 2015 -

  • $12.7 million directly related to the acquisition of Rockwood and $2.4 million in connection with other significant projects. After income taxes, these charges totaled $5.5 million, or $0.06 per share.

Year ended December 31, 2015 -

  • $123.9 million directly related to the acquisition of Rockwood and $8.4 million in connection with other significant projects. After income taxes, these charges totaled $84.6 million, or $0.76 per share.

(6)  Included in Interest and financing expenses for the three months and year ended December 31, 2016 is a loss on early extinguishment of $1.9 million ($1.5 million after income taxes, or $0.01 per share) related to the redemption of the term loan issued in October 2015. The three months and year ended December 31, 2015 includes a loss on early extinguishment of $5.4 million ($3.5 million after income taxes, or $0.03 per share) related to the redemption of senior notes issued by the Company's wholly-owned subsidiary, Rockwood Specialties Group, Inc.

(7)  Included in Interest and financing expenses for the year ended December 31, 2015 is $1.6 million ($1.0 million after income taxes, or $0.01 per share) of interest and financing expenses associated with senior notes we issued in the fourth quarter of 2014 in connection with the acquisition of Rockwood, which did not close until January 12, 2015.

(8)  Other adjustments included the following:

Three months ended December 31, 2016 -

  • A net loss of $0.9 million on the sales of properties included in Selling, general and administrative expenses, as well as $2.4 million of environmental charges related to a site formerly owned by Albemarle, a $1.1 million gain related to a previously disposed of site in China and a loss of $1.0 million on the sales of properties included in Other income (expenses), net. After income taxes, these net charges totaled $2.4 million, or $0.03 per share.

Year ended December 31, 2016 -

  • A net loss of $0.9 million on the sale of properties included in Selling, general and administrative expenses, as well as $2.4 million of environmental charges related to a site formerly owned by Albemarle and a $1.1 million gain related to a previously disposed of site in China included in Other income (expenses), net. After income taxes, these net charges totaled $2.0 million, or $0.02 per share.

Year ended December 31, 2015 -

  • $4.4 million ($2.8 million after income taxes, or $0.03 per share) for amortization of bridge facility fees and other financing fees related to the acquisition of Rockwood.

(9)  Included in Equity in net income of unconsolidated investments (net of tax) for the three months and year ended December 31, 2015 is an impairment charge of $2.0 million ($0.02 per share) related to our unconsolidated investment in Fábrica Carioca de Catalisadores SA.

(10) Included in Income tax expense (benefit) for the three months and year ended December 31, 2016 are expense items of $18.4 million ($0.16 per share) and $20.0 million ($0.18 per share), respectively, related primarily to a tax gain from restructuring the ownership of a foreign subsidiary, foreign tax rate changes, provision to return adjustments and changes in valuation allowances necessary due to the restructuring.   Included in Income tax expense (benefit) for the three months and year ended December 31, 2015 are benefits of $43.1 million, or $0.37 per share, primarily related to the release of certain tax reserves associated with lapses in statutes of limitations and audit closures.

(c)   On June 17, 2016, the Company entered into a definitive agreement to sell the Chemetall Surface Treatment business to BASF SE. On December 14, 2016, the Company closed the sale of this business for cash proceeds of approximately $3.1 billion, net of estimated purchase price adjustments, and recorded an after-tax gain of $135.0 million in 2016 related to the sale of this business. In the fourth quarter of 2016, we reversed a discrete non-cash charge of $381.5 million due to a change in the Company's assertion over book and tax basis differences related to a U.S. entity being sold, as well as a net discrete non-cash charge of $29.8 million related to a change in the Company's assertion over reinvestment of foreign undistributed earnings, both of which were recorded in previous quarters in 2016.

(d)   Totals may not add due to rounding.

(e)   The change in working capital increased $239.2 million for the year ended December 31, 2016 primarily as a result of the increase in income taxes payable from the gain on the sale of the Chemetall Surface Treatment business of $253.0 million.

Additional Information

It should be noted that adjusted net income attributable to Albemarle Corporation ("adjusted earnings"), adjusted net income from continuing operations, adjusted diluted earnings per share attributable to Albemarle Corporation, adjusted diluted earnings per share from continuing operations, non-operating pension and OPEB items per diluted share, non-recurring and other unusual items per diluted share, adjusted effective income tax rates, EBITDA, adjusted EBITDA, EBITDA margin and adjusted EBITDA margin are financial measures that are not required by, or presented in accordance with, accounting principles generally accepted in the United States, or GAAP. These non-GAAP measures should not be considered as alternatives to net income attributable to Albemarle Corporation ("earnings"). These measures are presented here to provide additional useful measurements to review our operations, provide transparency to investors and enable period-to-period comparability of financial performance. The Company's chief operating decision maker uses these measures to assess the ongoing performance of the Company and its segments, as well as for business and enterprise planning purposes.

A description of other non-GAAP financial measures that we use to evaluate our operations and financial performance, and reconciliation of these non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP, can be found in the Investors section of our website at www.albemarle.com, under "Non-GAAP Reconciliations" under "Financials." Also, see below for supplemental reconciliations of the non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP. The Company does not provide a reconciliation of forward looking non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP, as the Company is unable to estimate significant non-recurring or unusual items without unreasonable effort. The amounts and timing of these items are uncertain and could be material to the Company's results calculated in accordance with GAAP.

ALBEMARLE CORPORATION AND SUBSIDIARIES
Non-GAAP Reconciliations
(In Thousands)
(Unaudited)

See below for a reconciliation of adjusted net income attributable to Albemarle Corporation ("adjusted earnings"), adjusted net income from continuing operations, EBITDA and adjusted EBITDA, the non-GAAP financial measures, to Net income attributable to Albemarle Corporation ("earnings"), the most directly comparable financial measure calculated and reported in accordance with GAAP. Adjusted earnings is defined as earnings before the non-recurring, other unusual and non-operating pension and OPEB items as listed below. EBITDA is defined as earnings before discontinued operations, interest and financing expenses, income taxes, and depreciation and amortization. Adjusted EBITDA is defined as EBITDA and the non-recurring, other unusual and non-operating pension and OPEB items as listed below.


Three Months Ended


Year Ended


December 31,


December 31,


2016


2015


2016


2015

Net income attributable to Albemarle Corporation

$

602,090


$

174,252


$

643,675


$

334,906

Add back:








Income from discontinued operations (net of tax)

(559,974)


(13,402)


(202,131)


(32,476)

Earnings from continuing operations

42,116


160,850


441,544


302,430

Add back:








Non-operating pension and OPEB items from continuing operations
(net of tax)

17,868


(22,160)


17,608


(24,588)

Non-recurring and other unusual items from continuing operations
(net of tax)

28,844


(30,634)


(55,374)


114,336

Adjusted net income from continuing operations

88,828


108,056


403,778


392,178

Income from discontinued operations (net of tax)

559,974


13,402


202,131


32,476

Add back:








Non-operating pension and OPEB items from discontinued
operations (net of tax)

3,425


(6,553)


5,798


(7,738)

Non-recurring and other unusual items from discontinued operations
(net of tax)

(550,868)


1,254


(128,340)


22,471

Adjusted net income attributable to Albemarle Corporation

$

101,359


$

116,159


$

483,367


$

439,387









Adjusted diluted earnings per share attributable to Albemarle
Corporation

$

0.89


$

1.03


$

4.27


$

3.94









Weighted-average common shares outstanding – diluted

113,563


112,608


113,239


111,556









Net income attributable to Albemarle Corporation

$

602,090


$

174,252


$

643,675


$

334,906

Add back:








Income from discontinued operations (net of tax)

(559,974)


(13,402)


(202,131)


(32,476)

Interest and financing expenses

18,321


19,457


65,181


81,650

Income tax expense (benefit)

34,728


(30,646)


96,263


11,134

Depreciation and amortization

49,687


38,368


190,975


181,173

EBITDA

144,852


188,029


793,963


576,387

Non-operating pension and OPEB items

26,368


(31,385)


25,589


(35,300)

Non-recurring and other unusual items (excluding items associated
with interest expense)

16,164


17,837


(61,335)


214,913

Adjusted EBITDA

$

187,384


$

174,481


$

758,217


$

756,000









Net sales

$

696,655


$

722,610


$

2,677,203


$

2,826,429

EBITDA margin

20.8 %


26.0 %


29.7 %


20.4 %

Adjusted EBITDA margin

26.9 %


24.1 %


28.3 %


26.7 %










 

 

See below for a reconciliation of adjusted EBITDA on a segment basis, the non-GAAP financial measure, to Net income attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reporting in accordance with GAAP.

 

 


Lithium
and
Advanced
Materials


Bromine
Specialties


Refining
Solutions


Reportable
Segments
Total


All
Other


Corporate


Consolidated
Total


% of
Net
Sales

Three months ended December 31, 2016:
















Net income (loss) attributable to Albemarle
Corporation

$

75,021


$

37,143


$

48,107


$

160,271


$

(1,711)


$

443,530


$

602,090


86.5

%

Depreciation and amortization

27,478


9,806


9,236


46,520


1,673


1,494


49,687


7.1

%

Non-recurring and other unusual items
(excluding items associated with interest
expense)






16,164


16,164


2.3

%

Interest and financing expenses






18,321


18,321


2.6

%

Income tax expense






34,728


34,728


5.0

%

Income from discontinued operations (net
of tax)






(559,974)


(559,974)


(80.4)

%

Non-operating pension and OPEB items






26,368


26,368


3.8

%

Adjusted EBITDA

$

102,499


$

46,949


$

57,343


$

206,791


$

(38)


$

(19,369)


$

187,384


26.9

%

















Three months ended December 31, 2015:
















Net income attributable to Albemarle
Corporation

$

60,602


$

32,121


$

42,072


$

134,795


$

23,137


$

16,320


$

174,252


24.1

%

Depreciation and amortization

16,539


10,101


8,642


35,282


1,316


1,770


38,368


5.3

%

Non-recurring and other unusual items
(excluding items associated with interest
expense)

738



1,971


2,709



15,128


17,837


2.5

%

Interest and financing expenses






19,457


19,457


2.7

%

Income tax benefit






(30,646)


(30,646)


(4.2)

%

Income from discontinued operations (net
of tax)






(13,402)


(13,402)


(1.9)

%

Non-operating pension and OPEB items






(31,385)


(31,385)


(4.3)

%

Adjusted EBITDA

$

77,879


$

42,222


$

52,685


$

172,786


$

24,453


$

(22,758)


$

174,481


24.1

%

















Year ended December 31, 2016:
















Net income (loss) attributable to Albemarle
Corporation

$

261,394


$

187,364


$

202,874


$

651,632


$

131,301


$

(139,258)


$

643,675


24.0

%

Depreciation and amortization

101,966


39,562


36,089


177,617


7,302


6,056


190,975


7.1

%

Non-recurring and other unusual items
(excluding items associated with interest
expense)





(123,831)


62,496


(61,335)


(2.3)

%

Interest and financing expenses






65,181


65,181


2.4

%

Income tax expense






96,263


96,263


3.6

%

Income from discontinued operations (net
of tax)






(202,131)


(202,131)


(7.6)

%

Non-operating pension and OPEB items






25,589


25,589


1.0

%

Adjusted EBITDA

$

363,360


$

226,926


$

238,963


$

829,249


$

14,772


$

(85,804)


$

758,217


28.3

%

















Year ended December 31, 2015:
















Net income (loss) attributable to Albemarle
Corporation

$

148,821


$

186,474


$

161,585


$

496,880


$

32,781


$

(194,755)


$

334,906


11.8

%

Depreciation and amortization

84,069


36,179


34,039


154,287


18,183


8,703


181,173


6.4

%

Non-recurring and other unusual items
(excluding items associated with interest
expense)

79,977



1,971


81,948


3,029


129,936


214,913


7.6

%

Interest and financing expenses






81,650


81,650


2.9

%

Income tax expense






11,134


11,134


0.4

%

Income from discontinued operations (net
of tax)






(32,476)


(32,476)


(1.1)

%

Non-operating pension and OPEB items






(35,300)


(35,300)


(1.2)

%

Adjusted EBITDA

$

312,867


$

222,653


$

197,595


$

733,115


$

53,993


$

(31,108)


$

756,000


26.7

%

 

 


Lithium


PCS


Total
Lithium and
Advanced
Materials

Three months ended December 31, 2016:






Net income attributable to Albemarle Corporation

$

65,529


$

9,492


$

75,021

Depreciation and amortization

23,568


3,910


27,478

Adjusted EBITDA

$

89,097


$

13,402


$

102,499







Three months ended December 31, 2015:






Net income attributable to Albemarle Corporation

$

43,251


$

17,351


$

60,602

Depreciation and amortization

13,142


3,397


16,539

Non-recurring and other unusual items

738



738

Adjusted EBITDA

$

57,131


$

20,748


$

77,879







Year ended December 31, 2016:






Net income attributable to Albemarle Corporation

$

198,852


$

62,542


$

261,394

Depreciation and amortization

86,862


15,104


101,966

Adjusted EBITDA

$

285,714


$

77,646


$

363,360







Year ended December 31, 2015:






Net income attributable to Albemarle Corporation

$

63,473


$

85,348


$

148,821

Depreciation and amortization

70,014


14,055


84,069

Non-recurring and other unusual items

79,977



79,977

Adjusted EBITDA

$

213,464


$

99,403


$

312,867

 

See below for a reconciliation of the adjusted effective income tax rate, the non-GAAP financial measure, to the effective income tax rate, the most directly comparable financial measure calculated and reporting in accordance with GAAP.

 


Income from
continuing
operations before
income taxes and
equity in net income
of unconsolidated
investments


Income tax expense
(benefit)


Effective income tax
rate

Three months ended December 31, 2016:






As reported

$

70,185


$

34,728


49.5

%

Non-recurring, other unusual and non-operating pension and OPEB
items from continuing operations

44,453


(2,259)



As adjusted

$

114,638


$

32,469


28.3

%







Three months ended December 31, 2015:






As reported

$

130,606


$

(30,646)


(23.5)

%

Non-recurring, other unusual and non-operating pension and OPEB
items from continuing operations

(10,338)


44,600



As adjusted

$

120,268


$

13,954


11.6

%







Year ended December 31, 2016:






As reported

$

515,264


$

96,263


18.7

%

Non-recurring, other unusual and non-operating pension and OPEB
items from continuing operations

(33,825)


3,941



As adjusted

$

481,439


$

100,204


20.8

%







Year ended December 31, 2015:






As reported

$

310,744


$

11,134


3.6

%

Non-recurring, other unusual and non-operating pension and OPEB
items from continuing operations

157,501


96,830



As adjusted

$

468,245


$

107,964


23.1

%

 

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/albemarle-reports-strong-2016-earnings-finish-and-record-cash-flow-from-operations-300414325.html